Tlc Biopharmaceuticals, Inc.
Clinical trials sponsored by Tlc Biopharmaceuticals, Inc., explained in plain language.
-
New shot aims to ease post-surgery pain without opioids
Symptom relief Recruiting nowThis study tests a new medicine called TLC590 for pain after different types of surgery. About 120 adults aged 18 to 70 will receive the drug to see how well it works and how safe it is. The goal is to find the best dose that controls pain with fewer side effects.
Phase: PHASE2 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 04, 2026 16:30 UTC
-
New shot aims to slash post-surgery pain and opioid use
Symptom relief Recruiting nowThis study tests an experimental pain-relief injection called TLC590 in 300 adults having bunionectomy (foot bone surgery). The goal is to see if it reduces pain for 3 days after surgery and helps people avoid stronger opioid painkillers. Participants are randomly assigned to get…
Phase: PHASE3 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:00 UTC